Since the p63+ GCB-DLBCL group had a higher portion of patients with high-risk DLBCL (Table 1) which may have confounded the analysis [44], patients with low-risk and high-risk DLBCL were analyzed separately. This evidence concerns the gene TP63 and diffuse large B-cell lymphoma.